Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | MGAM | O43451 | 1/20 | 0.37 |
| ▸ | SI | P14410 | 1/20 | 0.37 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | MPI | P34949 | 1/20 | 0.33 |
| ▸ | PDE4A | P27815 | 1/20 | 0.33 |
| ▸ | TOP1 | P11387 | 1/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1428140 | 1.00 | LMNA (0.39) | LMNAL3MBTL1TDP1MGAMSI | |
| SCHEMBL2318762 | 1.00 | LMNA (0.39) | LMNAL3MBTL1TDP1MGAMSI | |
| SCHEMBL287865 | 1.00 | LMNA (0.39) | LMNAL3MBTL1TDP1MGAMSI | |
| SCHEMBL8970781 | 1.00 | LMNA (0.39) | LMNAL3MBTL1TDP1MGAMSI | |
| SCHEMBL19859337 | 0.88 | MPI (0.34) | LMNAL3MBTL1MGAMSIMPI | |
| SCHEMBL19859338 | 0.88 | MPI (0.34) | LMNAL3MBTL1MGAMSIMPI | |
| SCHEMBL3142523 | 0.88 | AKR1B1 (0.37) | LMNAL3MBTL1AKR1B1MPI | |
| SCHEMBL5453628 | 0.88 | AKR1B1 (0.37) | LMNAL3MBTL1AKR1B1MPI | |
| SCHEMBL183626 | 0.88 | AKR1B1 (0.37) | LMNAL3MBTL1AKR1B1MPI | |
| SCHEMBL5770928 | 0.88 | AKR1B1 (0.37) | LMNAL3MBTL1AKR1B1MPI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117384308-A | Radix tetrastigme polysaccharide prepared based on Phellinus fermentation and application thereof | 浙江省林业科学研究院 | 2024-01-12 | — | — | CN | claimed |
| CN-120081957-A | Stropharia rugoso-annulata polysaccharide and preparation method and application thereof | 河南农业大学 | 2025-06-03 | — | — | CN | disclosed |
| CN-115998760-B | Application of Pleurotus citrinopileatus polysaccharide in preparing anti-inflammatory drugs | 河南大学 | 2024-01-26 | — | — | CN | disclosed |
| CN-117384308-A | Radix tetrastigme polysaccharide prepared based on Phellinus fermentation and application thereof | 浙江省林业科学研究院 | 2024-01-12 | — | — | CN | disclosed |
| WO-2023220793-A1 | METHOD FOR SCREENING POTENTIALLY NEUROPROTECTIVE PHARMACEUTICALS OR SUBSTANCES, KIT FOR SCREENING PHARMACEUTICALS OR SUBSTANCES, AND USE OF A GENE PANEL | FUNDAÇÃO OSWALDO CRUZ (BR) | 2023-11-23 | — | — | WO | disclosed |
| CN-114591448-B | Mulberry and phellinus linteus fruiting body manna galactosan and preparation and application thereof | 浙江省林业科学研究院 | 2023-06-06 | — | — | CN | disclosed |
| CN-115998760-A | Application of Pleurotus citrinopileatus polysaccharide in preparing anti-inflammatory drugs | 河南大学 | 2023-04-25 | — | — | CN | disclosed |
| WO-2023006130-A1 | FISH SUBSTITUTE | RIVERA RESTREPO ANA MARIA (CO) | 2023-02-02 | — | — | WO | disclosed |
| US-11518891-B2 | Method of using water erodible marine antifouling coating | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2022-12-06 | — | — | US | disclosed |
| CN-114591448-A | Phellinus igniarius sporophore mannogalactan and preparation and application thereof | 浙江省林业科学研究院 | 2022-06-07 | — | — | CN | disclosed |
| EP-0177882-A2 | Antibiotic A 40926 complex and its pure factors PA, PB, A, B and BO | GRUPPO LEPETIT S.p.A. (IT) | 1986-04-16 | — | — | EP | disclosed |
| US-4578468-A | Antibiotic LL-D42067β | AMERICAN CYANAMID COMPANY (US) | 1986-03-25 | — | — | US | disclosed |
| US-4578271-A | Biologically active WS 6049 substances, a process for the production thereof and their pharmaceutical compositions | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1986-03-25 | — | — | US | disclosed |
| US-4551533-A | Antibiotic LL-D42067α | AMERICAN CYANAMID COMPANY (US) | 1985-11-05 | — | — | US | disclosed |
| US-4510134-A | X 14868A OR LL-23024B | AMERICAN CYANAMID CO. (US) | 1985-04-09 | — | — | US | disclosed |
| US-4451456-A | Antitumor antibacterial agents | BRISTOL-MYERS COMPANY (US) | 1984-05-29 | — | — | US | disclosed |
| US-4407946-A | AEROBIC FERMENTATION OF ACTINOMADURA | AMERICAN CYANAMID COMPANY (US) | 1983-10-04 | — | — | US | disclosed |
| US-4375542-A | ANTIACNE, ANTITUMOR, ANTIMALARIAL, ANTIBACTERIAL, AND ANTIINFLAMMATORY AGENT | SCHERING CORPORATION (US) | 1983-03-01 | — | — | US | disclosed |
| US-4360458-A | PEPTIDE ANTIBIOTICS, ANTIBIOTIC BBM-928 | BRISTOL-MYERS COMPANY (US) | 1982-11-23 | — | — | US | disclosed |
| US-4328211-A | Antibiotic Actinomadura-L-31 A, B | KAKEN CHEMICAL CO., LTD. (JP) | 1982-05-04 | — | — | US | disclosed |